Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Dermatologist

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44379   clinical trials with a EudraCT protocol, of which   7391   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    89 result(s) found for: Dermatologist. Displaying page 1 of 5.
    1  2  3  4  5  Next»
    EudraCT Number: 2006-007019-25 Sponsor Protocol Number: Delusional Parasitosis 1/Dec 2006 Start Date*: 2008-01-21
    Sponsor Name:Barts and the London NHS Trust
    Full Title: Pilot open trial of efficacy of Risperidone in Delusional Parasitosis
    Medical condition: Delusional Parasitosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012242 Delusion of parasitosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-002069-30 Sponsor Protocol Number: 13069 Start Date*: 2008-12-05
    Sponsor Name:Bayer Vital GmbH
    Full Title: A randomized, double-blind, single centre, placebo-controlled pilot study to assess on a molecular level the influence of a 5 % dexpanthenol ointment in subjects with previously injured skin by inv...
    Medical condition: Biopsy wounds on healthy volunteers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002029-40 Sponsor Protocol Number: 1001 Start Date*: 2013-08-23
    Sponsor Name:Karolinska Institutet
    Full Title: Aprepitant – effect and safety in treatment of atopic dermatitis
    Medical condition: Atopic Dermatitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2005-005624-13 Sponsor Protocol Number: 509002.01.403 Start Date*: 2006-03-15
    Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG
    Full Title: Investigation on treatment effect and safety of Hametum® Wund- und Heilsalbe in patients with drug induced skin symptoms. An open phase IV trial [Untersuchung zu Behandlungseffekt und Verträglichk...
    Medical condition: Patients with drug induced skin symptoms
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-001158-42 Sponsor Protocol Number: 014-012/08 Start Date*: 2008-05-21
    Sponsor Name:Dermatologikum Hamburg
    Full Title: Proof-of-concept study: Prüfung der Wirksamkeit und der Verträglichkeit von Botulinum-Toxin (Xeomin®) bei der Behandlung von Krähenfüßen im Vergleich zu Vistabel® im intraindividuellen Vergleich
    Medical condition: Moderate to severe crow`s feet
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052611 Crow's feet LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001157-18 Sponsor Protocol Number: 014-011/08 Start Date*: 2008-05-19
    Sponsor Name:Dermatologikum Hamburg
    Full Title: Proof-of-concept study: Prüfung der Wirksamkeit und der Verträglichkeit von Botulinum-Toxin (Xeomin®) bei der Behandlung von Krähenfüßen im Vergleich zu Dysport® im intraindividuellen Vergleich
    Medical condition: Moderate to severe crow`s feet
    Disease: Version SOC Term Classification Code Term Level
    9.1 10052611 Crow's feet LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-000152-42 Sponsor Protocol Number: BS-HAU-2011001 Start Date*: 2011-07-07
    Sponsor Name:Medical Faculty, University Magdeburg
    Full Title: An evaluator-blind controlled parallel-group study to assess efficacy and safety of Skinoren 15% gel and Differin 0.1 % gel for the treatment and maintenance treatment of facial acne vulgaris and l...
    Medical condition: Acne vulgaris late type acne
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-011625-13 Sponsor Protocol Number: ACA-NETH-07-15 Start Date*: 2009-10-05
    Sponsor Name:Abbott
    Full Title: "PSOGEN:Effect adalimumab op zelfbeeld en seksueel functioneren bij matige en ernstige psoriasis van de anogenitale regio; prospectief, open label pilot onderzoek"
    Medical condition: Anogenital Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    1 10016776 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-005568-24 Sponsor Protocol Number: 214-06/06 Start Date*: 2007-03-29
    Sponsor Name:Dermatologikum Hamburg
    Full Title: Prüfung der Wirksamkeit und der Verträglichkeit von Botulinum-Toxin (Xeomin®) in verschiedenen Verdünnungen Evaluation of the Efficacy and Safety of Botulinumtoxin (Xeomin®) in different dilutions
    Medical condition: Moderate to severe glabellar frown lines
    Disease: Version SOC Term Classification Code Term Level
    8.1 10052609 Glabellar frown lines LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002730-36 Sponsor Protocol Number: CaEP68962 Start Date*: 2019-11-14
    Sponsor Name:Department of Dermatology, Bispebjerg Hospital
    Full Title: Calcium electroporation for basal cell carcinomas – a ’Proof of concept’ study
    Medical condition: Basal cell carcinomas
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004864 10042503 Superficial basal cell carcinoma LLT
    21.1 100000004864 10073093 Nodular basal cell carcinoma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-002531-18 Sponsor Protocol Number: 69HCL16_0062 Start Date*: 2018-10-31
    Sponsor Name:Hospices Civils de Lyon
    Full Title: Topical Everolimus versus placebo for the treatment of facial angiofibromas in patients with tuberous sclerosis complex. A phase II/III, multicentre, randomized, double-blind, placebo-controlled st...
    Medical condition: angiofibromas
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10002429 Angiofibroma PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003959-21 Sponsor Protocol Number: BAP00731 Start Date*: 2007-09-25
    Sponsor Name:Basilea Pharmaceutica Ltd.
    Full Title: Open label treatment of patients with chronic hand dermatitis who have participated in a clincal trial involving oral alitretinoin
    Medical condition: Relapsed Chronic Hand Dermatitis (CHaD) Refractory to Topical Therapy
    Disease: Version SOC Term Classification Code Term Level
    9.1 10066695 Chronic hand dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) DE (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-002686-39 Sponsor Protocol Number: LEO19123-C22 Start Date*: 2006-09-11
    Sponsor Name:LEO Pharmaceutical Products Ltd. A/S (LEO Pharma A/S)
    Full Title: LEO19123 Cream in the Treatment of Hand Eczema A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatment of...
    Medical condition: Hand eczema
    Disease: Version SOC Term Classification Code Term Level
    8.1 10058898 Hand dermatitis PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-004161-41 Sponsor Protocol Number: CL-068-II-01 Start Date*: 2005-12-15
    Sponsor Name:Idea AG
    Full Title: Efficacy and Safety of IDEA-068 in Plaque Psoriasis
    Medical condition: chronic stable plaque type psoriasis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000253-30 Sponsor Protocol Number: LP0075-34 Start Date*: 2012-11-08
    Sponsor Name:LEO Pharma A/S
    Full Title: An exploratory study evaluating the efficacy of cromoglicate cream compared to cream vehicle in the treatment of itch in psoriasis
    Medical condition: itchy psoriasis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10050576 Psoriasis vulgaris LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003215-78 Sponsor Protocol Number: MBL 0202 INT Start Date*: 2005-11-16
    Sponsor Name:LEO Pharma A/S
    Full Title: Calcipotriol plus Betamethasone Dipropionate Gel Compared to Betamethasone Dipropionate in the Gel Vehicle, Calcipotriol in the Gel Vehicle and the Gel Vehicle alone in Psoriasis Vulgaris.
    Medical condition: Psoriasis vulgaris on the trunk and/or limbs
    Disease: Version SOC Term Classification Code Term Level
    6.1 10050576 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) IE (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2009-017858-12 Sponsor Protocol Number: LEO 22811-S22 Start Date*: 2010-05-11
    Sponsor Name:LEO Pharma A/S
    Full Title: A phase 2a proof of concept study comparing three doses of an oral solution of LEO 22811 with a placebo oral solution for the treatment of psoriasis vulgaris
    Medical condition: Psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2020-002644-23 Sponsor Protocol Number: MB_PDT_1 Start Date*: 2020-07-23
    Sponsor Name:Dept. of Dermatology, Zealand University Hospital, Roskilde
    Full Title: Photodynamic therapy of antifungal resistant dermatophytes
    Medical condition: Competent patients over 18 years old with mycological verified antifungal resistant dermatophytosis
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10043870 Tinea infections HLT
    20.0 10021881 - Infections and infestations 10043868 Tinea cruris PT
    20.0 10021881 - Infections and infestations 10060889 Tinea infection PT
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    20.0 10021881 - Infections and infestations 10049591 Tinea imbricata PT
    20.0 10021881 - Infections and infestations 10067197 Tinea manuum PT
    20.0 10021881 - Infections and infestations 10043872 Tinea NOS LLT
    20.1 10021881 - Infections and infestations 10043869 Tinea infection NOS LLT
    20.0 10021881 - Infections and infestations 10043867 Tinea corporis LLT
    20.0 10021881 - Infections and infestations 10043864 Tinea LLT
    20.0 10021881 - Infections and infestations 10053041 Tinea trichophytina cruris LLT
    20.0 10021881 - Infections and infestations 10073383 Tinea of hand LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-001153-10 Sponsor Protocol Number: X4P-001-103 Start Date*: 2020-02-05
    Sponsor Name:X4 Pharmaceuticals Incorporated
    Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients with WHIM Syndrome with Open-Label Extension
    Medical condition: WHIM Syndrome
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004850 10010512 Congenital immunodeficiency LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: FR (Trial now transitioned) DK (Trial now transitioned) HU (Completed) ES (Ongoing) PL (Completed) AT (Completed) DE (Completed) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-005344-83 Sponsor Protocol Number: PBD-0313 Start Date*: 2007-02-09
    Sponsor Name:Probiodrug AG
    Full Title: A Randomized, Double-blind, Placebo and Active Treatment-Controlled Study in Psoriatic Patients to Assess the Tolerability, Pharmacokinetics and Efficacy of a Cream Formulation Containing 3% of P32/98
    Medical condition: Psoriasis is a common inherited autoimmune disease that affects 2-3% of the world-wide population. There are several recognized forms of psoriasis, such as plaque psoriasis, which is also known as ...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10037153 Psoriasis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Feb 08 21:33:52 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA